Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2002
10/10/2002WO2002079382A2 B-ephrin regulation of g-protein coupled chemoattraction; compositions and methods of use
10/10/2002WO2002079375A1 Rapid assessment of coagulation activity in whole blood
10/10/2002WO2002079268A2 Tuning the properties of conjugated polyelectrolytes and application in a biosensor platform
10/10/2002WO2002079256A1 Antibody and utilization thereof
10/10/2002WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002WO2002079243A2 Gonococcal proteins and nucleic acids
10/10/2002WO2002079238A2 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
10/10/2002WO2002079232A2 Reducing the immunogenicity of fusion proteins
10/10/2002WO2002079230A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002WO2002079228A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/10/2002WO2002079217A1 A hepatitis b virus surface antigen mutant and methods of detection thereof
10/10/2002WO2002079085A2 Surface modification of porous silicon
10/10/2002WO2002078947A1 Sensor surfaces for detecting analytes
10/10/2002WO2002078848A2 Holding device, particularly for body fluids, comprising a separating device, and a separating device therefor
10/10/2002WO2002078847A1 Instrument and method for recovering nucleic acid
10/10/2002WO2002078846A1 Instrument and method for collecting nucleic acids
10/10/2002WO2002078835A2 Substrates, preparation and use
10/10/2002WO2002078720A2 Antibiotics from bacteria isolated from amphibian skin
10/10/2002WO2002078643A2 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002WO2002078642A2 Differentially-expressed and up-regulated polynucleotides and polypeptides in breast cancer
10/10/2002WO2002078636A2 Detection and treatment of colorectal cancer
10/10/2002WO2002078617A2 Materials and methods for treatment of cancer and identification of anti-cancer compounds
10/10/2002WO2002078610A2 Pak2: modulators of lymphocyte activation
10/10/2002WO2002078533A2 Integrated sample testing meter
10/10/2002WO2002078526A2 Cancer-testis antigens
10/10/2002WO2002078524A2 Translational profiling
10/10/2002WO2002078520A2 IL-1ss INHIBITION FOR MYELOMA AND RELATED DISORDERS
10/10/2002WO2002078516A2 Compositions and methods for the therapy and diagnosis of cancer
10/10/2002WO2002078512A2 Blood glucose tracking apparatus and methods
10/10/2002WO2002070552A8 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
10/10/2002WO2002066955A3 Method for screening compounds
10/10/2002WO2002054076A3 Sensor for luminescence optical determination of an analyte
10/10/2002WO2002047610A3 Marine actinomycete taxon for drug and fermentation product dicovery
10/10/2002WO2002041881A3 Repinotan kit
10/10/2002WO2002040159A3 Device for applying a magnetic field to a microtiter plate for biological separations
10/10/2002WO2002035237A3 Method for in vivo identification of intracellular epitopes
10/10/2002WO2002026820A3 Immunomodulatory protein derived from the yaba monkey tumor virus
10/10/2002WO2002025250A3 Isotopic gas analyzer and method of judging absorption capacity of carbon dioxide absorbent
10/10/2002WO2002024868A3 Non-human model of gestational and adult folate deficiency and uses thereof
10/10/2002WO2002016929A3 Urokinase peptide structure mimetics
10/10/2002WO2002016419A3 Progression suppressed gene 13 (psgen 13) and uses thereof
10/10/2002WO2002014866A3 Methods and universal monoclonal antibody array
10/10/2002WO2002012893A3 Microarrays of functional biomolecules, and uses therefor
10/10/2002WO2002010766A3 Assay method, peptides and reagent kits for testing mrp-specific inhibitors
10/10/2002WO2002006834A3 Nested sorting and high throughput screening
10/10/2002WO2002006512A3 Method for detecting uracil biosynthesis inhibitors and their use as herbicides
10/10/2002WO2002004956A9 Method of identifying conformation-sensitive binding peptides and uses thereof
10/10/2002WO2002004612A3 Drug metabolizing enzymes
10/10/2002WO2002000336A9 Composite arrays utilizing microspheres with a hybridization chamber
10/10/2002WO2001098353A3 Secreted proteins
10/10/2002WO2001094938A9 Flow cytometry-based hematology system
10/10/2002WO2001085982A3 Mixed cell systems for the detection of viruses
10/10/2002WO2001079550A3 Genetic testing for determining the risk of pouchitis development
10/10/2002WO2001077174A3 Human transporters and ion channels
10/10/2002WO2001075639A3 Method to evaluate the systemic exposure in toxicological and pharmacological studies
10/10/2002WO2001071039A3 Combined polynucleotide sequences as discrete assay endpoints
10/10/2002WO2001066798A3 Random truncation and amplification of nucleic acid
10/10/2002WO2001052718A9 Diet and activity monitoring device
10/10/2002WO2001033212A3 Method and computer code for portable sensing
10/10/2002WO1998018001A3 Combustibility monitor and monitoring method
10/10/2002WO1997022878A8 Reagent and method for differential determination of leukocytes in blood
10/10/2002US20020147999 Reducing neuronal tangles in alzhemier's patients; obtain human, administer modulator, monitor development of neuronal tangles in, reduction in neuronal tangles indicates modulator
10/10/2002US20020147996 Diagnosing and treating cancer cells using Sal2
10/10/2002US20020147548 Basecalling system and protocol
10/10/2002US20020147546 Fast microarray expression data analysis method for network exploration
10/10/2002US20020147330 Probe carrier for use in the diagnosis and analysis of genetic disorders
10/10/2002US20020147327 Glucocorticoid receptor protein for use in the treatment of arthritis and asthma
10/10/2002US20020147325 Antibodies to receptor protein kinases
10/10/2002US20020147321 Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful for serologic diagnosis of canine leishmaniosis and protein obtained
10/10/2002US20020147315 Method for removing endotoxin from the samples containing basic protein
10/10/2002US20020147306 Peptides that modulate the interaction of B class ephrins and PDZ domains
10/10/2002US20020147305 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002US20020147161 Novel antisense inhibition of rad51
10/10/2002US20020147145 Anticancer, antiproliferative agents
10/10/2002US20020147143 Diagnosis, therapy; anticancer agents
10/10/2002US20020147128 Stable aqueous solution; polyethersiloxane copolymer
10/10/2002US20020146852 Method to reduce leakage during a semi-conductor burn-in procedure
10/10/2002US20020146848 Separation particles
10/10/2002US20020146847 Imaging method
10/10/2002US20020146845 High throughput screening assay systems in microscale fluidic devices
10/10/2002US20020146844 Detection of preferential particles in sample; obtain sample, apply to binding zone, detect signal from bound particles
10/10/2002US20020146840 Microcolumns for the separation of analytes from a sample in the millisecond time scale
10/10/2002US20020146839 Multicapillary fraction collection system and method
10/10/2002US20020146838 Mass spectrometry of prostaglandins
10/10/2002US20020146835 Method for determining concentration of an analyte in a test strip
10/10/2002US20020146834 Device and method for in vitro detection of blood
10/10/2002US20020146833 Method and apparatus for rapid fat content determination
10/10/2002US20020146822 Differential treatment of selected parts of a single cell with different fluid components
10/10/2002US20020146820 Immunoreactive peptide CTL epitopes of human cytomegalovirus pp150
10/10/2002US20020146814 Device for bio-affinity material
10/10/2002US20020146806 Nucleotide sequences coding polypeptides for use in the treatment of rheumatic and autoimmune diseases
10/10/2002US20020146805 DNA encoding the human serine protease T
10/10/2002US20020146804 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of ischemic injury, nervous system and inflammatory disorders
10/10/2002US20020146797 Genetically engineered enzyme for use in the treatment of cell proliferative disorders
10/10/2002US20020146774 Smad2 phosphorylation and interaction with Smad4
10/10/2002US20020146773 ''Signalin'' family of TGFbeta signal transduction proteins, and uses related thereto
10/10/2002US20020146772 Nucleotide equences coding enzymatic polypeptide for use in the treatment of blood disorders and thrombosis
10/10/2002US20020146765 Acetylcholine receptor subunits
10/10/2002US20020146762 Generating mutant polypeptides; obtain protein sample, incubate wih mutagen, recover and evaluate protein activity
10/10/2002US20020146761 Detecting gram-negative bacterial infection in human; btain human, inject with labeled endotoxin neutralizing protein, detect label
1 ... 2733 2734 2735 2736 2737 2738 2739 2740 2741 2742 2743 2744 2745 2746 2747 2748 2749 2750 2751 2752 2753 ... 3937